Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 8Recruiting 3Terminated 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other hematologic neoplasm 2Head & Neck 2Plasma cell 1Myeloid 1Lymphoid 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Nasopharyngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 57pembrolizumab 54Cetuximab 43Radiotherapy 35Docetaxel 21Radiotherapy, Intensity-Modulated 20Paclitaxel 19Nivolumab 18Fluorouracil 18Carboplatin 17Radiation 14Radiosurgery 9Magnetic Resonance Spectroscopy 8Gemcitabine 8Everolimus 8Biopsy 8Surgical Procedures, Operative 7Oxaliplatin 7Erlotinib Hydrochloride 7Cyclophosphamide 7durvalumab 6avelumab 6Capecitabine 6spartalizumab 5epacadostat 5Surveys and Questionnaires 5Platinum 5Immunoglobulin G 5Gefitinib 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Induction Chemotherapy × Head & Neck × Clear all
NCT00828386 2019-01-18

NPC2006

Groupe Oncologie Radiotherapie Tete et Cou

Phase 3 Terminated
83 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT00002735 2015-09-30

SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue

SWOG Cancer Research Network

Phase 2 Terminated
68 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡